Peijia Medical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Yi Zhang
Chief executive officer
CN¥2.1m
Total compensation
| CEO salary percentage | 36.06% |
| CEO tenure | 13yrs |
| CEO ownership | 0.8% |
| Management average tenure | 5.6yrs |
| Board average tenure | 5.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | CN¥2m | CN¥740k | -CN¥227m |
| Sep 30 2024 | n/a | n/a | -CN¥239m |
| Jun 30 2024 | n/a | n/a | -CN¥252m |
| Mar 31 2024 | n/a | n/a | -CN¥322m |
| Dec 31 2023 | CN¥1m | CN¥740k | -CN¥393m |
| Sep 30 2023 | n/a | n/a | -CN¥460m |
| Jun 30 2023 | n/a | n/a | -CN¥528m |
| Mar 31 2023 | n/a | n/a | -CN¥468m |
| Dec 31 2022 | CN¥1m | CN¥1m | -CN¥408m |
| Sep 30 2022 | n/a | n/a | -CN¥449m |
| Jun 30 2022 | n/a | n/a | -CN¥491m |
| Mar 31 2022 | n/a | n/a | -CN¥533m |
| Dec 31 2021 | CN¥2m | CN¥1m | -CN¥574m |
Compensation vs Market: Yi's total compensation ($USD284.15K) is below average for companies of similar size in the US market ($USD2.68M).
Compensation vs Earnings: Yi's compensation has increased whilst the company is unprofitable.
CEO
Yi Zhang (56 yo)
Dr. Yi Zhang has been an Executive Director of Peijia Medical Limited since May 30, 2012. He serves as the Chairman and Chief Executive Officer at Peijia Medical Limited and served as its Chief Technology...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | no data | CN¥2.05m | 0.80% $ 3.6m | |
| Chief Financial Officer | 6.1yrs | no data | no data | |
| Chief Operating Officer | 7.8yrs | no data | no data | |
| Chief Technology Officer | 4.3yrs | no data | no data | |
| Executive Director | 5.3yrs | CN¥182.00k | 0.16% $ 705.0k | |
| Executive Director & Company Secretary | 12.6yrs | CN¥2.11m | 2.09% $ 9.4m | |
| Vice President of Sales | 5.1yrs | no data | no data | |
| Vice President of Marketing | 5.8yrs | no data | no data | |
| Company Secretary | 2.9yrs | no data | no data |
Experienced Management: PEJM.F's management team is seasoned and experienced (5.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 13yrs | CN¥2.05m | 0.80% $ 3.6m | |
| Executive Director | 6.8yrs | CN¥182.00k | 0.16% $ 705.0k | |
| Executive Director & Company Secretary | 12.6yrs | CN¥2.11m | 2.09% $ 9.4m | |
| Independent Non-Executive Director | 5.3yrs | CN¥1.40m | no data | |
| Independent Non-Executive Director | 3.7yrs | CN¥319.00k | no data | |
| Independent Non-Executive Director | 5.3yrs | CN¥319.00k | no data | |
| Non-Executive Director | 5.9yrs | no data | no data | |
| Independent Non-Executive Director | 5.3yrs | CN¥1.41m | no data | |
| Non-Executive Director | 5.6yrs | no data | no data | |
| Non-Executive Director | 4.8yrs | no data | no data |
Experienced Board: PEJM.F's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 07:54 |
| End of Day Share Price | 2025/03/12 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Peijia Medical Limited is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Yu | China International Capital Corporation Limited |
| Yuan Gao | China International Capital Corporation Limited |
| Wen Dai | Huatai Research |